Article

Zinc as a possible treatment for tinnitus

Department of Otolaryngology, Head and Neck Surgery, The University of Iowa, Iowa City, IA, USA.
Progress in brain research (Impact Factor: 5.1). 02/2007; 166:279-85. DOI: 10.1016/S0079-6123(07)66026-9
Source: PubMed

ABSTRACT Zinc is an essential trace element present in all organs, tissues, fluids, and secretions of the body and it is widely distributed in the central nervous system, including the auditory pathway in synapses of the VIII nerve and in the cochlea. Zinc is an essential component of Cu/Zn superoxide dismutase (SOD) and in certain enzymes and it is important for proper function of the immune system. Three possible mechanisms have linked zinc to tinnitus; cochlear Cu/Zn SOD activity, synaptic transmission, and depression. Evidences in the literature suggest prevalence rates of zinc deficiency in individuals with tinnitus from 2 to 69%, affecting elderly individuals more frequently. Four among five small studies indicate that administration of zinc has a beneficial effect on tinnitus but these results still have to be confirmed in clinical trials with larger samples using a cross-over design, validated tinnitus handicap questionnaires, measurements of tinnitus magnitude, and accessing the coexistence of other symptoms such as depression, phonophobia, and hyperacusis.

1 Follower
 · 
67 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tinnitus is the perception of sound without an external source. More than 50 million people in the United States have reported experiencing tinnitus, resulting in an estimated prevalence of 10% to 15% in adults. Despite the high prevalence of tinnitus and its potential significant effect on quality of life, there are no evidence-based, multidisciplinary clinical practice guidelines to assist clinicians with management. The focus of this guideline is on tinnitus that is both bothersome and persistent (lasting 6 months or longer), which often negatively affects the patient's quality of life. The target audience for the guideline is any clinician, including nonphysicians, involved in managing patients with tinnitus. The target patient population is limited to adults (18 years and older) with primary tinnitus that is persistent and bothersome.
    Otolaryngology Head and Neck Surgery 10/2014; 151(2 Suppl):S1-S40. DOI:10.1177/0194599814545325 · 1.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to assess zinc levels in tinnitus patients, and to evaluate the effects of zinc deficiency on tinnitus and hearing loss.Methods One-hundred patients, who presented to an outpatient clinic with tinnitus between June 2009 and 2014, were included in the study. Patients were divided into three groups according to age: Group I (patients between 18 and 30 years of age); Group II (patients between 31 and 60 years of age); and Group III (patients between 61 and 78 years of age). Following a complete ear, nose and throat examination, serum zinc levels were measured and the severity of tinnitus quantified using the Tinnitus Severity Index Questionnaire (TSIQ). Patients were subsequently asked to provide a subjective judgment regarding the loudness of their tinnitus. The hearing status of patients was evaluated by audiometry and high-frequency audiometry. An average hearing sensitivity was calculated as the mean value of hearing thresholds between 250 and 20.000 Hz. Serum zinc levels between 70 and 120 μg/dl were considered normal. The severity and loudness of tinnitus, and the hearing thresholds of the normal zinc level and zinc-deficient groups, were compared.ResultsTwelve of 100 (12%) patients exhibited low zinc levels. The mean age of the zinc-deficient group was 65.41 ± 12.77 years. Serum zinc levels were significantly lower in group III (p < 0.01). The severity and loudness of tinnitus was greater in zinc-deficient patients (p = 0.011 and p = 0.015, respectively). Moreover, the mean thresholds of air conduction were significantly higher in zinc-deficient patients (p = 0.000).Conclusion We observed that zinc levels decrease as age increases. In addition, there was a significant correlation between zinc level and the severity and loudness of tinnitus. Zinc deficiency was also associated with impairments in hearing thresholds.
    American Journal of Otolaryngology 11/2014; DOI:10.1016/j.amjoto.2014.11.001 · 1.08 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study demonstrates a fluorescent method for in vivo sensing of the dynamic change of Zn2+ concentration in auditory cortex microdialysate induced by salicylate with N’-(7-nitro-2,1,3-benzoxadiazole-4-yl)-N,N,N’-tris(pyridine-2-ylmethyl) ethane-1,2-diamine (NBD-TPEA) as a probe. The excellent property of NBD-TPEA probe makes it possible to achieve a high selectivity for Zn2+ sensing with the co-existence of amino acids and other metal ions as well as the species commonly existing in the cerebral system. To validate the method for in vivo fluorescence sensing of Zn2+ in rat brain, we pre-mix the microdialysates in vivo sampled from auditory cortex with NBD-TPEA probe and then perfuse the mixtures into a fluorescent cuvette for continuous-flow fluorescence detection. The method demonstrated here shows a linear relationship between the signal output and Zn2+ concentration within the concentration range from 0.5 microM to 4 microM, with a detection limit of 156 nM (S/N = 3). The basal level of extracellular Zn2+ in auditory cortex microdialysate is determined to be 0.52 microM (n = 4). This value is increased by the injection of 100 mg/mL of salicylate (1 microL/min, 5 min, i.p.), reaches a peak at the time point of 90 min, and levels off with time. Such an increase is attenuated by the injection of MK-801, a potent and specific NMDA receptor antagonist, after the pre-injection of 100 mg/mL salicylate for 5 min. This study offers a fluorescent method for in vivo sensing of Zn2+ in rat brain that could be useful for investigation on chemical processes involved in brain functions.
    The Analyst 09/2014; 140(1). DOI:10.1039/C4AN01443J · 3.91 Impact Factor